 HOUSTON--BUSINESS WIRE--Kiromic BioPharma, Inc. Nasdaq: KRBP, an immuno-oncology target discovery and gene-editing company, with a proprietary artificial intelligence neural network platform Diamond AI to develop novel oncology therapeutics, has announced the completion and certification of its GMP facility in Houston, Texas: GMP facility construction is complete and certified to meet all FDA required regulatory guidelines. GMP facility is ready to support our upcoming first in-human, off 